10:30am ET
Investing
Major Biotechs See a Retreat in Short Interest
The February 28 short interest data have been compared with the previous report, and short interest decreased in most of the selected biotech stocks.
Companies
/Healthcare
Gilead Sciences Inc
$148.09
▼ $0.68 (−0.46%) today
Markets closed · 2:23am ET
GILD Coverage
Page 238:45am ET
Investing
Top Analyst Upgrades and Downgrades: American Express, Amgen, Encana, Gilead, Tesla and Many More
The top analyst upgrades, downgrades and initiations seen on Thursday include American Express, Amgen, Encana, Gilead Science and Tesla.
10:15am ET
Health and Healthcare
Short Sellers Hike Their Bets in Major Biotechs
The February 15 short interest data have been compared with the previous report, and short interest increased in all the selected biotech stocks.
9:05am ET
Investing
Jefferies Says Buy These Dividend-Paying Companies That Missed Expectations
These five top companies havehit some economic potholes but are primed for a comeback. They all are well known, make a variety of consumer and commercial products and will be around in…
9:15am ET
Investing
What Analysts Are Prescribing Gilead After Earnings
After Gilead Sciences reported fourth-quarter earnings on Tuesday, the stock hit a new multiyear low and analysts took the opportunity to slash their price targets.
Chris Lange 9:55am ET
Health and Healthcare
Major Biotechs Scare Off Loads of Short Sellers
As we approached Trump’s inauguration, the health care sector in general rallied. Now it’s time to see what the bears have to say about this rally.
4:04pm ET
Investing
Vista Outdoor, Fossil Group Dive into Thursday’s 52-Week Low Club
Vista Outdoor, Gilead Sciences, Fitbit, and Fossil posted new 52-week lows on Thursday.
4:08pm ET
Investing
Gilead Sciences, Fitbit Plunge into Wednesday’s 52-Week Low Club
Gilead Sciences, Gale Biopharma, Teva, and Fitbit post new 52-week lows Wednesday.
12:35pm ET
Health and Healthcare
What Analysts Are Saying About Gilead Sciences After Earnings
24/7 Wall St. has included some highlights from the Gilead Sciences earnings report, as well as what analysts are saying afterward.
Chris Lange 11:35am ET
Health and Healthcare
Wednesday’s Biggest Biopharma Movers
Not that many biotech and pharma companies were on the move Wednesday, but a few of the smaller caps made splash, while one giant company posted a massive loss.
9:15am ET
Investing
Top Analyst Upgrades and Downgrades: Broadcom, Cheniere, Gilead, Microchip Tech, Twitter, Lennar, Bankrate and Many More
The op analyst upgrades, downgrades and initiations seen on Wednesday include Broadcom, Cheniere Energy, Gilead Sciences, Microchip Technology, Twitter, Lennar and Bankrate.
4:20pm ET
Health and Healthcare
Why Gilead Earnings Were Not Up to Snuff
Gilead Sciences Inc. (NASDAQ: GILD) reported its fourth-quarter earnings after the markets closed on Tuesday. The company posted $2.70 in earnings per share (EPS) and $7.3 billion in revenue, compared with the…
Chris Lange 10:10am ET
Health and Healthcare
What to Expect From Gilead Earnings
Gilead Sciences is set to report its fourth-quarter financial results after the markets close on Tuesday.
Chris Lange 10:25am ET
Investing
Top 7 Earnings for the Week Ahead
24/7 Wall St. has put together a preview of GM, Twitter, NVIDIA and some of the major companies reporting their quarterly results this week as earnings season winds down.
8:10am ET
Investing
7 Dirt Cheap S&P 500 Value Stocks for Massive Upside Potential for 2017 and 2018
With stocks at all-time highs, perhaps there may be some better safety in companies that are known and that offer "value" as well. It is this value segment that has come front…